Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel in Adolescents with Inadequately Controlled Partial-onset Seizures
NCT01161524Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2010
- Primary completion
- Jun 2013
- Modality
- Classical Binding Small Molecules
- Countries
- 11
01
Overview
Phase 2, randomised, double-blind trial of perampanel in epilepsy (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Change From Baseline to Week 19 in Cognition Drug Research (CDR) System Global Cognition Score. Started Sep 2010; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01161524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01161524.